| Aug 6 |
Nyxoah GAAP EPS of -€0.43, revenue of €0.77M
|
| Aug 6 |
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
|
| Jul 29 |
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
|
| Jul 15 |
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
|
| Jul 1 |
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
|
| May 31 |
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
|
| May 28 |
Information on the Total Number of Voting Rights and Shares
|
| May 15 |
Nyxoah reports Q1 results
|
| May 10 |
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
|
